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Delayed cell death by mitotic catastrophe is a frequent mode of
solid tumor cell death after g-irradiation, a widely used treatment
of cancer. Whereas the mechanisms that underlie the early
g-irradiation-induced cell death are well documented, those that
drive the delayed cell death are largely unknown. Here we show
that the Fas, tumor necrosis factor-related apoptosis-inducing
ligand(TRAIL) and tumor necrosis factor (TNF)-a death receptor
pathways mediate the delayed cell death observed after g-irradi-
ation of breast cancer cells. Early after irradiation, we observe the
increased expression of Fas, TRAIL-R and TNF-R that ﬁrst sen-
sitizes cells to apoptosis. Later, the increased expression of FasL,
TRAIL and TNF-a permit the apoptosis engagement linked to
mitotic catastrophe. Treatments with TNF-a, TRAIL or anti-
Fas antibody, early after radiation exposure, induce apoptosis,
whereas the neutralization of the three death receptors pathways
impairs the delayed cell death. We also show for the ﬁrst time that
irradiated breast cancer cells excrete soluble forms of the three
ligands that can induce the death of sensitive bystander cells.
Overall, these results deﬁne the molecular basis of the delayed cell
death of irradiated cancer cells and identify the death recep-
tors pathways as crucial actors in apoptosis induced by targeted
as well as non-targeted effects of ionizing radiation.
Introduction
While cells from breast cancer are generally refractory to early in-
duction of apoptosis in response to ionizing radiation (IR) and
chemotherapeutic agents (1,2), these treatments promote loss of pro-
liferative capacity and/or late induction of cell death. Radiation-
induced late cell death is often accounted for by a mitotic catastrophe,
deﬁned as a type of cell death occurring during mitosis or resulting
from failed mitosis (3) and characterized by a prolonged G2 arrest and
subsequent cell death. Recently, apoptosis and mitotic catastrophe
have been functionally linked and mitotic catastrophe is now deﬁned
as a subtype of caspase-mediated death resulting from a combination
of deﬁcient cell cycle checkpoints and persistence of DNA damage
(4,5). During mitotic catastrophe, apoptosis could occur either during
or close to metaphase in a p53-independent manner or after asymmet-
ric cell division and tetraploidy in a partially p53-dependent manner
(6,7). This death pathway might account for the late apoptosis ob-
served after IR or adriamycin treatment of breast cancer cells.
Numerous signaling pathways have been implicated in the regula-
tion of apoptosis of breast cancer cells and several reports have sug-
gested a link between radiation- or chemotherapy-induced apoptosis
of breast cancer cells and activation of death receptor pathways
(8–10). In breast cancer cells, chemotherapeutic agents and IR can
induce the expression of Fas, tumor necrosis factor-related apoptosis-
inducing ligand (TRAIL)-R1 and -R2, tumor necrosis factor (TNF)-
R1 and -R2, the receptors of the three main death receptors pathways:
i.e., respectively, FasL, TRAIL and TNF-a signaling pathways
(11–14). In addition, activation of the death receptors pathways has
been shown to occur when exogenous death receptors ligands were
added to breast cancer cells treated previously by antitumor agents or
radiation and this addition leads to synergistic effects (12,15,16).
Finally, irradiation can sensitize mammary cells to TRAIL-mediated
apoptosis, both in vivo and in vitro (17,18). Addition of the ligands
induces apoptosis through the formation of the death-inducing signal-
ing complex, i.e. receptor aggregation, recruitment of the adaptor
molecule Fas-associated death domain (FADD) and subsequent bind-
ing and activation of caspases 8 and 10 (19). All these results indicate
that the three death receptors ligands, TNF-a, TRAIL and FasL, may
act as major participants in apoptosis of solid tumors and might be
used as potential anticancer agents (20). However, increased expres-
sion of death receptor ligands has been only observed after treatments
with drugs, such as paclitaxel and sodium butyrate, which modulate
Fas/FasL expression and induce early cell death of breast cancer cells
(21,22). These data strongly suggest that death receptor signaling
pathways might play an important role in the apoptosis of breast
cancer cells, but no direct link has ever been established between
reproductive cell death observedafter irradiation of breastcancer cells
and activation of death receptor signaling.
We have shown previously that c-irradiation of breast cancer cell
lines led to delayed cell death after growth arrest (23). We now
showed that irradiated breast cancer cell lines died by apoptosis due
to mitotic catastrophe. The FasL, TRAIL and TNF-a death-inducing
signaling pathways mediated the delayed cell death of irradiated
breast cancer cells through interactions of their ligands and receptors.
Increased expression of the ligands occurred late and accounted for
delayed radiation-induced apoptosis. Finally, we showed that these
ligands were also produced as soluble forms whose secretion can
induce the death of sensitive bystander cells.
Materials and methods
Cell cultures
T-47D, H-466B, ZR-75-1, BT-20, MDA-MB-231, HBL-100 and HEK 293 cell
lines were obtained from the American Type Culture Collection (Rockville,
MD). Cell line characteristics are summarized in supplementary Table I (avail-
ableatCarcinogenesisOnline).Allcell lines,exceptBT-20, weremaintainedin
Dulbecco’s modiﬁed Eagle medium 4.5 g/l glucose, 0.11 g/l sodium pyruvate,
glutamate (GlutaMAX 1TM) and pyridoxine, supplemented with 5% fetal calf
serum, penicillin, streptomycin and amphotericin B (antibiotic–antimycotic
mix) (all from Life Technologies, Cergy-Pontoise, France). BT-20 cells were
grown in RPMI 1640 medium with GlutaMAX 1TM,2 0m MN-2-hydroxye-
thylpiperazine-N#-2-ethanesulfonicacidand2.5mMsodiumpyruvate.Allcells
cultures were done in 5% CO2 and 95% humidity.
Abbreviations: FADD, Fas-associated death domain; ICM, irradiated
conditioned medium; IR, ionizing radiation; NICM, non-irradiated conditioned
medium; PARP1, poly-ADP ribose polymerase-1; SM, standard medium; TNF,
tumor necrosis factor; TRAIL, tumor necrosis factor-related apoptosis-inducing
ligand.
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All biochemicals were from Sigma (Saint Quentin Fallavier, France) unless
otherwise speciﬁed. Monoclonal anti-human Fas antibody (clone DX2), re-
combinant human TRAIL and TNF-a and soluble recombinant chimera (Fas/
Fc, TRAIL-R1/Fc and TNF-R1/Fc) were from R&D Systems (Lille, France).
Irradiation
Cells were plated 48 h prior to irradiation. On day 0, cells were irradiated in
a serum-free medium, using a 137Cs irradiation unit at dose rate of  2 Gy/min,
and then incubated with fresh medium.
Proliferation, survival and apoptosis
Cell proliferation and survival analyses were performed in two or more in-
dependent experiments, by scoring at least 300 cells each time. Discrimination
between viable and dead cells (including dead cells in the supernatant) was
performed by trypan blue exclusion. Apoptosis was analyzed by in situ
TUNEL assay using APO-BrdUTM kit (Becton Dickinson, Le Pont-de-Claix,
France) according to the manufacturer’s recommendation.
Flow cytometry
For cell cycle analysis, cells were trypsinized and harvested by centrifugation at
1400 r.p.m for 10 min, washed in phosphate-buffered saline, ﬁxed in 70% cold
ethanol and stored at  20C. Before analysis, cells were washed in phosphate-
buffered saline and stained in phosphate-buffered saline containing 25 lg/ml
propidium iodide (Sigma) and 50 lg/ml RNase A (Roche Diagnostics, Meylan,
France) for 30 min at 37C. Samples were analyzed using a FACScalibur ﬂow
cytometer (Becton Dickinson) on at least 20 000 cells. Cellular debris, ﬁxation
artifacts and doublets were gated out with FL2-area and FL2-width parameters.
The cell cycle was analyzed using Modﬁt software (Verity, Becton Dickinson).
RNA extraction and quantitative real-time RT–PCR
For the ﬁrst-strand cDNA synthesis, 1 lg of total RNA, extracted with RNA Plus
(Quantum Biotechnologies, Illkirch, France), was mixed with 1 lM of random
primer p(dN)6 (Roche Diagnostic) and 250 lM deoxynucleoside triphosphate
(Life Technologies) in a 1  reverse buffer (6.7 mM MgCl2,6 7m MT r i s – H C l ,
pH 8.8, 16.6 mM (NH4)2SO4), incubated for 5 min at 65C, placed on ice before
adding 200 U of mouse moloney murine leukemia virus reverse transcriptase (Life
Technologies) in a ﬁnal volume of 20 ll, further incubated for 30 min at 42Ca n d
then incubated for 3 min at 72C to inactivate reverse transcriptase (24). RT–PCR
was performed with an ABI Prism 7300 detection apparatus (Applied Biosystems,
Courtabeuf, France), using the SYBR Green PCR Core Reagent kit (Applied
Biosystems) or the Taqman Universal Master Mix according to the recommenda-
tions of the manufacturer. The Ct value was determined with the Sequence De-
tection System software. For Taqman assays, the primers were from Applied
Biosciences: Hs99999905_m1 (glyceraldehyde 3-phosphate dehydrogenase),
Hs99999903_m1 (ACTG1/b-actin), Hs00531110_m1 (FAS/TNFRSF6),
Hs00181225_m1 (FASLG/FasL/TNFSF6), Hs00269492_m1 (TRAIL-R1/
TNFRSF10A), Hs00366272_m1 (TRAIL-R2/TNFRSF10B), Hs00533560_m1
Fig. 1. Characterization of the delayed cell death of breast cancer cell lines after a 10 Gy irradiation. (a) Time course of cell death of six different breast
cancer cell lines. Viable and dead cells were assessed by trypan blue staining. Results shown corresponded to the mean ± SD of two to four independent experiments.
(b) Cell cycle analysis of 10 Gy-irradiated cell lines over 5 days (d0–d5). Similar results were obtained in at least two different experiments. (c) Kinetics of cleavage
of caspase 3 and PARP1 in T-47D cells at different times after 10 Gy irradiation. The western blot analysis shown is representative of three independent experiments.
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433(TNF-R1/TNFRSF1A), Hs00153550_m1 (TNF-R2/TNFRSF1B),
Hs00174128_m1 (TNF/TNF-alpha/TNFSF2) and Hs0000538709_m1 (FADD).
For SYBR Green PCR assays, primers [forward (F) and reverse (R)] are for
TRAIL/TNFSF10: GCAACTCCGTCAGCTCGTTAG (F) and GGCCCA-
GAGCCTTTTCATTC (R). Levels of gene expression were normalized using
GENORM software (25), which determines the most stable reference (housekeep-
ing) genes from a set of tested candidate reference genes in a given sample panel.
A gene expression normalization factor can be calculated for each sample based
on the geometric mean of a user-deﬁned number of reference genes. In our experi-
ments, levels of gene expression were normalized using glyceraldehyde 3-
phosphate dehydrogenase and b-actin.
Western blot
Cell lysates (30 lg) or cell culture supernatants (12 ll) were subjected to
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis and proteins were
transferred and detected using a chemiluminescence procedure. Antibodies
Fig. 2. The death receptor pathways are involved in delayed radiation-induced cell death. (a) Kinetics of cleavage of caspase 8 in T-47D cells after a 10 Gy
irradiation. The western blot analysis shown is representative of three independent experiments. (b) Analysis of FADD expression by quantitative RT–PCR and
westernblot at differenttimes after a 10 Gyirradiationof T-47D cells.The representativeresults fromtwo independentexperimentsare shown.Forall western blot
analyses, b-actin was used as a loading control. (c) and (d) mRNA levels of death receptors and corresponding ligands after a 10 Gy irradiation of T-47D cells.
These mRNA levels were determined by quantitative RT–PCR. Normalization was performed as indicated in Materials and Methods and the basal expressiono n
day 0 was normalized to 1 (except for FasL, undetectable on day 0 and ﬁxed at 1 on day 2). Each value corresponds to the mean value of at least two independent
PCRs performed from three independent experiments. Error bars correspond to standard deviation.
Fig. 3. Kinetics of expression of functional receptors and ligands of death receptors pathways after a 10 Gy irradiation of T-47D cells. (a) The kinetics of protein
expression of receptors (Fas, TRAIL-R1, TRAIL-R2, TNF-R1 and TNF-R2) and ligands (FasL and TRAIL) of death receptors pathways were studied by western
blot analysis using cellular extracts from 10 Gy-irradiated T-47D cells. b-Actin was used as loading control. (b), (c) and (d) Analysis of soluble forms of death
receptors ligands in culture medium of 10 Gy-irradiated T-47D cells. TNF-a and TRAIL were detected by ELISA in supernatant of irradiated and non-irradiated
cells each day for 7 days (b and c, left panel). To analyze ligand secretion over 24 h, medium was changed on day 5 and ELISAwas performed on supernatant on
day 6 (b and c, right panel). Each value corresponds to the mean of at least two independent measurements from two independent experiments. Error bars
correspond to standard deviation. (d) Soluble FasL was detected by western blot after direct loading cell culture supernatants (see Materials and Methods). The
representative results from three independent experiments are shown. (e) Irradiation sensitizes T-47D cells to TNF-a, TRAIL and anti-Fas agonist antibody. Cells
were treated with anti-Fas agonist antibody (2 lg/ml), TRAIL (1 ng/ml) and TNF-a (0.5 ng/ml) 24 h after 10 Gy irradiation and 24 h later, viable and dead cells
were counted after trypan blue staining. Results correspond to the mean ± SD of three independent experiments.
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434directed against FasL(sc-957), TNF-R1 (sc-8436) and TNF-R2 (sc-8041) were
from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies directed against
FADD (# 2782), caspase 3 (# 9662) and caspase 8 (# 9746) were from Cell
Signaling Technology (Ozyme, France). Anti-PARP1 antibody (AM30) and
anti-TRAIL antibody (# 556468) was from BD Biosciences (Le Pont-De-
Claix, France), anti-b-actin antibody (A-5316) was from Sigma, anti-TNF-a
antibody (AF-210-NA) was from R&D Systems, anti-TRAIL-R1 antibody (#
06-744) was from Upstate (Millipore, France) and anti-TRAIL-R2 antibody (#
2019) was from ProSci (Coger S.A., France).
Enzyme-linked immunosorbent assay
The kinetics of TNF-a and TRAIL secretion into the media of irradiated and
non-irradiated cells was quantiﬁed using Quantikine ELISA kits (R&D
Systems) according to the manufacturer’s recommendation.
Medium transfer experiments
Potential bystander effects were investigated by medium transfer experiments
as described by Mothersill and Seymour (26,27). Breast cancer cells were
grown to 20–30% conﬂuence and then 10 Gy irradiated or not. After 6 days,
conditioned medium was removed, ﬁltered and transferred to ﬂasks containing
cells 10 Gy irradiated or not 24 h before. Conditioned medium was used pure
or diluted with standard medium (SM). Cell death was measured 24 h later.
Results
IRs induce late mitotic catastrophe and apoptosis of breast cancercell
lines
Radiation-induced cell death was ﬁrst studied over a period of 7 days
on six human breast cancer cell lines. No signiﬁcant cell death was
observed during the ﬁrst 24 h after a 10 Gy irradiation (Figure 1a).
This observation reﬂects the lack of primary apoptotic response ob-
served in breast tumors, indicating that these cell lines were good
models to study the delayed cell death of breast cancer cells after
c-irradiation. Cell death started on day 2 after c-irradiation for one
cell line (BT-20), on days 3–5 for the other cell lines and increased
with time indicating delayed cell death. Seven days after c-irradiation,
celldeathwasobservedinallcelllineswithaheterogeneouspercentage
of dead cells among the cell lines (Figure 1a). This delayed cell death
seemed independent of the p53 status; since ZR-75-1 cells expressed
a functional wild-type p53 protein, HBL-100 is a SV-40 transformed
cell line whereas all the other cells expressed a mutant p53 protein.
As this delayed cell death may be accounted for by a mitotic ca-
tastrophe subsequent to growth arrest, we analyzed the cell cycle
distribution and DNA content of the cells after irradiation of three
representative cell lines. Twenty-four hours after irradiation, these
three cell lines showed a G2/M arrest that lasted several days and 2
or 3 days after irradiation, a fraction of cells became polyploid (Figure
1b). The effect of such prolonged G2/M arrest has also been assessed
by colony-forming assays. A plating efﬁciency between 2   10 4 and
4   10 4 was observed after a 10 Gy irradiation of T-47D, indicating
an almost fully clonogenic inhibition. These results are fully in agree-
ment with the deﬁnition of mitotic catastrophe since irradiation pro-
mote loss of proliferative capacity, and cell death appeared after
a strong G2/M blockade and took place in cells during mitosis and/
or after a failed mitosis in polyploid cells.
We then investigated whether the c-irradiation-induced cell death
was due to apoptosis. Clear chromatin condensation and apoptotic
bodies were detected in the c-irradiated cells (data not shown), cas-
pase 3 activation through procaspase 3 cleavage, a hallmark of apo-
ptosis, started 3 days after c-irradiation and increased on days 4 and 5,
and PARP1, a target of caspase 3, was cleaved 4 days after radiation
exposure (Figure 1c). When we studied the activation of these two
proteins in dead ﬂoating cells, we observed that caspase 3 and PARP1
are almost fully cleaved, indicating that the majority of cells died by
apoptosis (Figure 1c). Finally, in situ TUNEL assay indicated that late
apoptosis occurred continuously during the last days of the kinetic
(supplementary Figure S1 is available at Carcinogenesis Online).
Taken together, these results indicated that, late after c-irradiation,
breast cancer cells died of a caspase-dependent apoptosis associated
with a mitotic catastrophe.
The death receptor pathways are activated after c-irradiation of
breast cancer cell lines
After c-irradiation of T-47D cells, we found activation of the caspase
8, which is known to trigger apoptotic signals from the death receptors
(Figure 2a). We also studied the expression of FADD, a downstream
key element of the death receptor pathways implicated in the death-
inducing signaling complex formation and potentially implicated in
the apoptotic process (12) and showed a signiﬁcant increase in FADD
expression 3 days after c-irradiation, both at the mRNA and protein
levels (Figure 2b). These results strongly suggested an involvement of
the death receptor pathways in the delayed cell death of the irradiated
cells.
We, thus, studied the mRNA levels of receptors and ligands of these
death receptors pathways. Fas, TRAIL-R2 and TNF-R2 mRNA levels
were signiﬁcantly increased 1 day after c-irradiation, i.e. before any de-
tectable cell death and this increase lasted throughout the time course of
the experiment (Figure 2c). This increase was restricted to these three
receptors as the mRNA levels of TRAIL-R1 and TNF-R1 remained
constant (Figure 2c). We then studied the kinetics of mRNAs expression
encoding the three ligands of the death receptors, FasL, TRAIL and
TNF-a, and showed a delayed increased expression of these mRNAs
that are highly expressed when apoptosis started (Figure 2d).
At the protein level, we found an early increased expression of Fas,
TRAIL-R2 and TNF-R2 and a late increased expression of two of
their ligands, FasL and TRAIL (Figure 3a). TNF-a is a soluble cyto-
kine and was undetectable in cell lysate but enzyme-linked immuno-
sorbent assay (ELISA) analysis of the c-irradiated cells supernatants
indicated a progressive increase of TNF-a concentration in these
supernatants (Figure 3b, left panel). Even if the culture medium
was renewed at day 5, a similar level of TNF-a was found 24 h later
(at day 6), indicating an increase in TNF-a secretion after irradiation
rather than a time-dependent accumulation of this cytokine (Figure
3b, right panel). Finally, we studied the expression of the truncated
and soluble forms of FasL and TRAIL (sFasL and sTRAIL, respec-
tively) and looked for sFasL and sTRAIL in the irradiated cell super-
natants. As for TNF-a, ELISA analysis indicated a late increased
secretion of sTRAIL (Figure 3c), and western blot analysis showed
Fig. 4. Neutralization of the death receptor pathways reduces radiation-
induced apoptosis. T-47D cells were 10 Gy-irradiated and treated or not with
a combination of Fas/Fc, TRAIL-R1/Fc and TNF-R1/Fc chimera (250, 100
and 100 ng/ml, respectively). These chimeras, which are cytokines designed
to neutralize apoptosis induced by the corresponding ligand, were added to
the culture medium at day 0, 3 and 5. Viable and dead cells were counted
after trypan blue staining. Results correspond to the mean ± SD of three
independent experiments.
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435the late expression of two forms of sFasL (these two forms were
described previously and correspond to distinct cleavage sites for
matrix metalloproteinases (28)) (Figure 3d).
As the Fas, TRAIL-R2 and TNF-R2 death receptors were overex-
pressed early after c-irradiation, we investigated whether irradiation
could set up all the components of the associated death receptor path-
ways. Sham or irradiated T-47D cells were treated 24 h later with
TNF-a, TRAIL or anti-Fas agonist antibody and cell death was ana-
lyzed 48 h after irradiation. Irradiation alone or TNF-a, TRAIL and
anti-Fas agonist without irradiation induced a weak cell death but,
when irradiated cells were treated with TNF-a, TRAIL or anti-Fas
agonist antibody, a signiﬁcant cell death was observed 48 h after
irradiation (Figure 3e).
Altogether, these results showed that the sequential expression of
different members of the death receptor pathways regulate the tim-
ing of radiation-induced apoptosis. The overexpression of the recep-
tors and the set up of the death receptor pathways occurred ﬁrst and,
later, the delayed cell death paralleled the kinetics of expression of
the three ligands, indicating that apoptosis occurred when the con-
centration of the ligands is sufﬁcient to stimulate the death signaling
pathways.
Neutralization of the death receptor pathways reduces radiation-
induced apoptosis
To study if the activation of the death receptor pathways is a causal
mechanism in the radiation-induced cell death of breast cancer cells,
we used soluble recombinant chimera (Fas/Fc, TRAIL-R1/Fc and
TNF-R1/Fc) that have been shown to inhibit the induced apoptosis of
the corresponding ligand (soluble as well as surface ligands). Irradiated
T-47D cells were treated at day 0, 3 and 5 with the soluble recombinant
chimera and cell death was analyzed 4–7 days after irradiation.
Whereas each inhibitor alone could not impair the radiation-induced
cell death (data not shown), the addition of the three inhibitors
together signiﬁcantly decreased the percentage of dead cells and
diminished the slope of the percentage of dead cells over the time
(Figure 4).
These results indicated that activation of death receptor pathways
partly mediated radiation-induced cell death and showed that the late
overexpression of death ligands is a causal key event in the late
radiation-induced apoptosis in breast cancer cells.
c-Irradiation-induced activation ofdeath receptor pathways occurs in
different human breast cancer cells
To study if activation of death receptor pathways in c-irradiation-
induced late cell death is restricted to the T-47D cell line or occurs
in different human breast cancer cells, we studied the expression of
the different components of the death receptor pathways in two other
breast cancer cell lines, ZR-75-1 and MDA-MB-231, as these cell
lines displayed different p53 status (wild-type and mutated, respec-
tively) and different and lower radiosensitivity as compared with
T-47D (Figure 1a). These two cell lines showed the same kinetics
of expression of the death receptors—Fas, TRAIL-R2 and TNF-
R2—than in T-47D cells (Figure 5a). The three ligands were also
lately expressed in irradiated MDA-MB-231 cells, but only two
ligands (FasL and TRAIL) were overexpressed in ZR-75-1 cells
(Figure 5b).
In conclusion, early expression of death receptors and late expres-
sion of death ligands after c-irradiation seemed to be a general
Fig. 5. Activationofdeathreceptorpathwaysisfoundin all irradiatedbreastcancer celllinesstudied.mRNAexpressionlevels of(a) deathreceptorsand(b) death
receptors ligands were analyzed in ZR-75-1 that expresses a wild-type p53 and MDA-MB-231 after 10 Gy irradiation by quantitative RT–PCR as in Figure 2.
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436phenomenon in breast cancer cells, independent of p53 with, as ex-
pected, features speciﬁc to the cell line used.
Soluble death ligands mediate a radiation-induced bystander effects
in breast cancer cells
As soluble death ligands were secreted by c-irradiated breast cancer
cells, we studied their potential-mediated bystander effects using
a 6-day conditioned medium from either 10 Gy-irradiated conditioned
medium (ICM) or non-irradiated conditioned medium (NICM) T-47D
cells. Cell death was measured 24 h after transfer of SM, ICM and
NICM to non-irradiated or irradiated T-47D cells. We did not observe
any cell death after transfer of SM, ICM or NICM to non irradiated
T-47D cells (Figure 6a). In contrast, when T-47D cells were irradiated
24 h before the transfer of conditioned medium, the rate of cell
death was not signiﬁcantly increased by NICM or MS treatments
but was more than three times increased after ICM treatment. The
increased cell death was similar after a 50% dilution of ICM with
SM, but did not occur after 25% or 10% dilution indicating a thresh-
old of death receptors ligands concentration for induced cell
death (Figure 6a). We also showed similar effects of the T-47D
ICM on irradiated MDA-MB-231, -BT-20 and -ZR-75-1 cell lines
(Figure 6b). Finally, we studied the cell death induced by ICM
of each cell line on the cell line itself and showed that all ICMs
induced cell death but only on irradiated cells (Figure 6c). These
results indicated that soluble factors present in ICM can induce cell
death of breast cancer cells only if these cells have been sensitized
by irradiation.
To show that the soluble factors, present in ICM, which can mediate
cell death, were related to FasL,TRAIL and/or TNF-a, we neutralized
the three ligands with the combined action of the three speciﬁc in-
hibitors used previously. ICM from irradiated T-47D was incubated
for 2 h with the inhibitors and transferred to irradiated T-47D cells. As
seen in Figure 6d, the addition of the inhibitors mixture decreased the
percentage of dead cells to background. We ﬁnally studied T-47D
ICM-induced cell death on the human embryonic kidney HEK 293
cell line known to constitutively express a high level of Fas and to
undergo apoptosis in response to Fas stimulation. We showed that cell
death occurred after addition of ICM, even when HEK 293 cells had
not been irradiated previously, and this death-inducing effect could
be similarly inhibited by FasL inhibitor or the mixture of the three
inhibitors (Figure 6e).
Taken together, these results strongly suggest that late secretion of
sFasL, sTRAIL and TNF-a by irradiated breast cancer cells partici-
pate to the induction of cell death of bystander cells if these cells are
sensitive to external death inducing stimuli.
Discussion
In this paper, we showed that irradiation of breast cancer cells lead to
a mitotic blockade followed by mitotic catastrophe associated with
apoptosis. For all analyzed breast cancer cell lines, apoptosis occurs
late after radiation exposure, is triggered by sequential overexpression
of death receptors and death receptor ligands and is associated with
characteristics of caspase-dependent apoptosis.
It has been suggested that prolonged growth arrest of epithelial cells
after irradiation could be followed by apoptosis or necrosis (2). In our
model, when studying ﬂoating dead cells after irradiation, we observed
the almost total cleavage of caspase 3, 8 and PARP1, strongly suggest-
ingthatapoptosisbutnotnecrosisisthemostimportantmodalityofcell
death after c-irradiation. Apoptosis occurred after a G2/M arrest and/or
Fig. 6. Radiation-induced bystander effects by members of the death receptors ligands. Bystander effects were studied using media transfer from irradiated cells.
(a) Media were conditioned for 6 days on 10 Gy-irradiated T-47D (irradiated conditioned medium: ICM) cells or non-irradiated T-47D (NICM) cells, ﬁltered and
transferred to T-47D cells which have been irradiated previously at 10 Gy or not irradiated. SM was used as control medium. ICM was used pure or 50%, 25%, and
10% diluted in SM; 24 h after media transfer, viable and dead cells were counted after trypan blue staining. (b) The effects of T-47D-conditioned media were
studied on three other breast cancer cell lines: MDA-MB-231, BT-20 and ZR-75-1, using the same protocol. (c) The effects of conditioned media from MDA-MB-
231,BT-20 andZR-75-1werestudied oncells ofthesametype,usingthesame protocol. (d) ICMfromT-47Dwerepretreatedornot,for2 h,witha combination of
Fas/Fc, TRAIL-R1/Fc and TNF-R1/Fc chimeras (2 lg/ml each). The effects of these inhibitors were studied on T-47D, using the same protocol. (e) The effects of
T-47D-conditioned mediawerestudied onthe humanembryonickidneycell lineHEK293thatconstitutively expressesthe Fasreceptorusingthesame protocol.A
FasL-speciﬁc inhibitor or a combination of death receptors ligands inhibitors was used to study the mediation of HEK 293 cell death. For all these studies, results
correspond to the mean ± Sd of three independent measurements.
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437in descendant cells having a 8 N DNA content indicating a mitotic
catastrophe related to two deﬁcient cell cycle checkpoints, i.e. spindle
perturbation and/or mitotic slippage (7,29).
The delayed apoptosis observed after c-irradiation of breast cancer
cells is strongly related to triggering of the apoptosis through the
death receptor pathways. Furthermore, the concomitant deregulation
of expression of the members of the three pathways studied, their
activation and the observation that their neutralization reduces signif-
icantly apoptosis, clearly indicated that all these pathways play
a causal role, and the late apoptosis could be the result of the sum
of the deregulation of these three pathways.
The triggering of apoptosis is mediated by early overexpression of
members of death receptors and late overexpression of the death
receptor ligands.Theoverexpression of the receptorshave beenalready
described after radiation exposure or therapeutics drugs treatment
(11,12,14–18), but we now showed an early set up of all the compo-
nents of the death receptor pathways after c-irradiation. Among the
death receptors, Fas, TRAIL-R2 and surprisingly TNF-R2 but not
TNF-R1 were overexpressed after c-irradiation. The two ﬁrst recep-
tors contain a death domain and transduce death signal by direct
activation of procaspase 8, whereas TNF-R2 has no death domain.
However, TNF-R1 is expressed in all studied cell lines and it was
shown previously that TNF-R2 can induce apoptosis by strongly en-
hancing the activation of TNF-R1 by TNF-a and also by inhibiting
nuclear factor kappa B-mediated protection (30), indicating that
TNF-R2 overexpression may sensitizes cells to TNF-a-mediated apo-
ptotic signal after c-irradiation. So, overexpression of the three recep-
tors may lead all to activation of the death receptor pathways, directly
for Fas and TRAIL-R2 and indirectly for TNF-R2, but always via
an increase of procaspase 8 cleavage. The death receptors ligands
started to be overexpressed 2 or 3 days after c-irradiation and their
kinetics of expression paralleled the appearance of apoptosis. Further-
more, neutralization of these ligands inhibited cell death. We also
showed that the ligand’s concentration is critical for cell death induc-
tion, dilution experiments of conditioned media indicating a threshold
effect rather than a dose–response effect. To our knowledge, this is the
ﬁrst time that late and concomitant overexpression of death ligands is
involved in radiation-induced death of epithelial tumor cells in relation
to mitotic catastrophe. Finally, our results indicate that death receptors
overexpression might be directly induced by c-irradiation, whereas the
deathreceptorsligands overexpression mightbe theconsequence ofthe
mitotic catastrophe in response to blockage of cell cycle checkpoints or
abnormal mitosis (29). Indeed, many regulatory elements that control
mitotic catastrophe, i.e. cell cycle-speciﬁc kinases (Cdk1, Plks, Aurora),
cell cycle checkpoint proteins, survivin, p53 and p21waf1/cip1 could also
be implicated in the regulation of death ligand expression (7,29).
We can detect soluble forms of the three death ligands TNF-a,
sFasL and sTRAIL in culture medium 5 days after radiation exposure,
and by medium transfer experiments, we showed that these ligands
caninduce the death of bystandercells. TNF-a is essentially described
as a soluble cytokine, whereas FasL and TRAIL are mainly described
as membrane-bound proteins. The cleavage of FasL and TRAIL by
speciﬁc proteases to produce soluble forms seemed to be induced by
c-irradiation and/or mitotic catastrophe and might be related to the
production of soluble forms of sFasL and sTRAIL in breast and colon
adenocarcinomas and in the immune system (31–33). So, secretion of
the three soluble ligands enhances the death signal induced by radi-
ation exposure and cause the death of sensitive bystander cells. These
soluble death receptors ligands could mediated cell death of all breast
cancer cells tested, because ICM from a cell line could induce cell
death in the other cell lines. However, we showed a death-inducing
effect on receiving breast cancer cells only if the cells were ﬁrst
irradiated or in HEK 293 cells, in which Fas is known to be consti-
tutively overexpressed. Taken together, all these results show that
death receptor signaling pathways play an important role in me-
dium-mediated death effect through soluble forms of death ligands.
Many non-targeted effects associated with exposure to IR have
been described and reactive oxygen species or cytokines have been
suggested as potential mediators of bystander effects such as genomic
instability or cell death of receiving cells (26,34–39). To date, only
one recent report characterizes extracellular factors implicated in the
bystander death-inducing effect and shows the release of sTRAIL and
TNF-a after X-ray irradiation of lung carcinoma cell lines (40). How-
ever, in this study, sTRAIL and TNF-a were produced early and
transiently after irradiation and were not implicated in delayed cell
death. In the study reported in this paper, we have unambiguously
characterized, on receiving sensitive breast cancer cells, a death-in-
ducingbystander effect whichwas mediatedby soluble formsof death
ligands and showed that excreted ligands of death receptor pathways
amplify the direct response to radiation by enhancing the rate of cell
death through a bystander effect. Our results were obtained on breast
cancer cell lines and we will investigated in the future if the phenom-
enons observed are also found in primary breast cancer tumors and
other types of tumors sensible to c-irradiation.
In conclusion, we have shown that three death receptor path-
ways—Fas, TRAIL-R and TNF-R—play a crucial role in the apopto-
sis and bystander effect that occurred after c-irradiation of breast
cancer cells. The sequential expression of the receptors and ligands
indicated why a synergy is observed between c-irradiation and acti-
vation of the death receptor signaling pathways and why apoptosis is
a late process after radiation exposure of tumor derived from epithe-
lial cells. The presence of soluble ligands in culture media indicated
that cell death induced by c-irradiation might not be restricted to
initially damaged cells but also, by bystander effect, to surrounding
cells sensitive to these diffusible factors. This bystander effect indicated
that the total response of the tumor cells and the tumor microenviron-
ment to c-irradiation may be broader than originally thought and ulti-
mately may have implications for radiation risk assessment.
Supplementary materials
Supplementary Table I and Figure S1 can be found at http://carcin.
oxfordjournals.org/
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